256 related articles for article (PubMed ID: 34494727)
1. Mammary Tumor Organoid Culture in Non-Adhesive Alginate for Luminal Mechanics and High-Throughput Drug Screening.
Fang G; Lu H; Rodriguez de la Fuente L; Law AMK; Lin G; Jin D; Gallego-Ortega D
Adv Sci (Weinh); 2021 Nov; 8(21):e2102418. PubMed ID: 34494727
[TBL] [Abstract][Full Text] [Related]
2. High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays.
Brandenberg N; Hoehnel S; Kuttler F; Homicsko K; Ceroni C; Ringel T; Gjorevski N; Schwank G; Coukos G; Turcatti G; Lutolf MP
Nat Biomed Eng; 2020 Sep; 4(9):863-874. PubMed ID: 32514094
[TBL] [Abstract][Full Text] [Related]
3. Gut Organoid as a New Platform to Study Alginate and Chitosan Mediated PLGA Nanoparticles for Drug Delivery.
Davoudi Z; Peroutka-Bigus N; Bellaire B; Jergens A; Wannemuehler M; Wang Q
Mar Drugs; 2021 May; 19(5):. PubMed ID: 34065505
[TBL] [Abstract][Full Text] [Related]
4. BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance.
Duarte AA; Gogola E; Sachs N; Barazas M; Annunziato S; R de Ruiter J; Velds A; Blatter S; Houthuijzen JM; van de Ven M; Clevers H; Borst P; Jonkers J; Rottenberg S
Nat Methods; 2018 Feb; 15(2):134-140. PubMed ID: 29256493
[TBL] [Abstract][Full Text] [Related]
5. Establishment and long-term culture of mouse mammary stem cell organoids and breast tumor organoids.
Cui J; Guo W
STAR Protoc; 2021 Jun; 2(2):100577. PubMed ID: 34124696
[TBL] [Abstract][Full Text] [Related]
6. High-throughput drug screening of fine-needle aspiration-derived cancer organoids.
Bergdorf K; Phifer C; Bharti V; Westover D; Bauer J; Vilgelm A; Lee E; Weiss V
STAR Protoc; 2020 Dec; 1(3):100212. PubMed ID: 33377106
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release.
Sabhachandani P; Sarkar S; Mckenney S; Ravi D; Evens AM; Konry T
J Control Release; 2019 Feb; 295():21-30. PubMed ID: 30550941
[TBL] [Abstract][Full Text] [Related]
8. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform.
Rajan SAP; Aleman J; Wan M; Pourhabibi Zarandi N; Nzou G; Murphy S; Bishop CE; Sadri-Ardekani H; Shupe T; Atala A; Hall AR; Skardal A
Acta Biomater; 2020 Apr; 106():124-135. PubMed ID: 32068138
[TBL] [Abstract][Full Text] [Related]
9. Alginate-based microfluidic system for tumor spheroid formation and anticancer agent screening.
Chen MC; Gupta M; Cheung KC
Biomed Microdevices; 2010 Aug; 12(4):647-54. PubMed ID: 20237849
[TBL] [Abstract][Full Text] [Related]
10. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids.
Schuster B; Junkin M; Kashaf SS; Romero-Calvo I; Kirby K; Matthews J; Weber CR; Rzhetsky A; White KP; Tay S
Nat Commun; 2020 Oct; 11(1):5271. PubMed ID: 33077832
[TBL] [Abstract][Full Text] [Related]
11. Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.
Abugomaa A; Elbadawy M; Yamanaka M; Goto Y; Hayashi K; Mori T; Uchide T; Azakami D; Fukushima R; Yoshida T; Shibutani M; Yamashita R; Kobayashi M; Yamawaki H; Shinohara Y; Kaneda M; Usui T; Sasaki K
Sci Rep; 2020 Jun; 10(1):9393. PubMed ID: 32523078
[TBL] [Abstract][Full Text] [Related]
12. High-throughput organo-on-pillar (high-TOP) array system for three-dimensional ex vivo drug testing.
Jun HR; Kang HJ; Ju SH; Kim JE; Jeon SY; Ku B; Lee JJ; Kim M; Kim MJ; Choi JJ; Noh JJ; Kim HS; Lee JW; Lee JK; Lee DW
Biomaterials; 2023 May; 296():122087. PubMed ID: 36924663
[TBL] [Abstract][Full Text] [Related]
13. Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening.
Du Y; Li X; Niu Q; Mo X; Qui M; Ma T; Kuo CJ; Fu H
J Mol Cell Biol; 2020 Aug; 12(8):630-643. PubMed ID: 32678871
[TBL] [Abstract][Full Text] [Related]
14. Establishing estrogen-responsive mouse mammary organoids from single Lgr5
Zhang L; Adileh M; Martin ML; Klingler S; White J; Ma X; Howe LR; Brown AM; Kolesnick R
Cell Signal; 2017 Jan; 29():41-51. PubMed ID: 27511963
[TBL] [Abstract][Full Text] [Related]
15. Patient-Derived Organoids of Cholangiocarcinoma.
Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380
[TBL] [Abstract][Full Text] [Related]
16. High-throughput screening in colorectal cancer tissue-originated spheroids.
Kondo J; Ekawa T; Endo H; Yamazaki K; Tanaka N; Kukita Y; Okuyama H; Okami J; Imamura F; Ohue M; Kato K; Nomura T; Kohara A; Mori S; Dan S; Inoue M
Cancer Sci; 2019 Jan; 110(1):345-355. PubMed ID: 30343529
[TBL] [Abstract][Full Text] [Related]
17. High-throughput compound evaluation on 3D networks of neurons and glia in a microfluidic platform.
Wevers NR; van Vught R; Wilschut KJ; Nicolas A; Chiang C; Lanz HL; Trietsch SJ; Joore J; Vulto P
Sci Rep; 2016 Dec; 6():38856. PubMed ID: 27934939
[TBL] [Abstract][Full Text] [Related]
18. Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition.
Zhao N; Powell RT; Yuan X; Bae G; Roarty KP; Stossi F; Strempfl M; Toneff MJ; Johnson HL; Mani SA; Jones P; Stephan CC; Rosen JM
Nat Commun; 2021 Jul; 12(1):4262. PubMed ID: 34253738
[TBL] [Abstract][Full Text] [Related]
19. Derivation of a robust mouse mammary organoid system for studying tissue dynamics.
Jamieson PR; Dekkers JF; Rios AC; Fu NY; Lindeman GJ; Visvader JE
Development; 2017 Mar; 144(6):1065-1071. PubMed ID: 27993977
[TBL] [Abstract][Full Text] [Related]
20. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
